HTXelerator, which is launching in September, is aimed at supporting future leaders and connecting them with the city's burgeoning tech scene. Photo via HoustonTX.gov

A new nonprofit program dedicated to preparing the future leaders of the city of Houston's is launching with the city's burgeoning innovation ecosystem in mind.

HTXelerator is a three-month program that trains its group of aspiring politicians on the nuts and bolts of city government. The program — designed to be similar to a tech accelerator — will launch out of The Cannon Downtown and The Ion in September. The idea to link the program with the startup and innovation community is intentional, says Randy Romman, executive director. Co-located with The Cannon and The Ion, Romman says he hopes the accelerator provides an opportunity for collisions between politics and innovation.

"Houston, in particular, needs more tech dollars and more people aware of tech dollars," he tells InnovationMap. "That's why we wanted this in The Cannon and The Ion — so that those people can sit in on these classes and participate. Our topics range from land use to economic development, transportation, and more. And hopefully these future leaders can learn something from the tech world."

Similar to a tech accelerator, the program concludes with a competition known as The Pitch, which enables each participant to put forward a policy platform for a hypothetical race.

"We have a competition that really prepares you to run for office — that's a little different from the other programs out there," Romman explains.

The accelerator, which is priced at $195 — a cost that is intentionally low to ensure accessibility, diversity, and equal representation, will prepare leaders for public service, specifically boards, commissions, and eventually city council, according to a press release from the program.

The courses will include immersive opening and closing weekend retreats, as well as 90-minute weekly education sessions include transportation, public safety, land use, diversity and social equity, economic development, homelessness, city finances, utilities, media training, and how to run a campaign.

"The Houston region continues to grow and subsequently so does the need for public leadership to reflect the city's dynamic diversity," says Renee Cross, senior director of the University of Houston's Hobby School of Public Affairs and HTXelerator board member, in the release. "HTXelerator will allow people with an interest in public service to learn from experts in government, non-profit organizations, academia and the private sector. Whether pursuing a leadership position or running for office, HTXelerator graduates will be ahead of the game."

There is no fee to apply, and the application, which is available online, is due by August 3. New cohort members will be announced August 13.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.